Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

LWAY US Equity

Lifeway Foods, Inc.Consumer Staples · Dairy Products · CIK 814586 · FY ends Dec 31
$25.93
+0.02 (+0.08%)
USD · as of 2026-08-21 · marketstack

LWAY · 10-K · period ended 2024-12-31

← all LWAY documents
filed 2025-03-14 · EDGAR original ↗

Our rendering of the filing — original pagination and typography are not reproduced, and tables are reduced to their short label cells (the figures live on FA). Nothing is summarized: every line below is the filing's own text.

blocks 337936 of 1,972168k characters rendered

ITEM 1A. RISK FACTORS

In evaluating and understanding us and our business,

you should carefully consider the risks described below, in conjunction with all of the other information included in this Annual Report

on Form 10-K, including “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained

in Part II, Item 7. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that

we are unaware of, or that we currently believe are not material, may become important factors that adversely affect our business. If

any of the events or circumstances described in the following risk factors actually occurs, our business, financial condition, results

of operations, and future prospects could be materially and adversely affected.

RISKS RELATED TO OUR BUSINESS

Our product categories face a high level of

competition, which could negatively impact our sales and results of operations.

We compete with a limited number of other domestic

kefir producers and consequently face a small amount of direct competition for kefir products. However, our kefir-based products compete

with other dairy products, notably spoonable and drinkable yogurt, and, increasingly, with non-dairy probiotic products that incorporate

kefir cultures but are not kefir. We face significant competition for limited retailer shelf space in each of our product categories.

Competition in our product categories is based on product innovation, product quality, price, brand recognition and loyalty, effectiveness

of marketing, promotional activity, and our ability to identify and satisfy consumer tastes and preferences. We believe that our brands

have benefited in many cases from being the first to introduce products in their categories, and their success has attracted competition

from other food and beverage companies that produce branded products, as well as from private label competitors. Some of our competitors,

such as Danone, General Mills, Chobani, Hain Celestial Group, and Nestle, have substantial financial and marketing resources. These competitors

and others may be able to introduce innovative products more quickly or market their products more successfully than we can, which could

cause our growth rate to be slower than we anticipate and could cause sales to decline.

We also compete with producers of non-dairy products

that have lower ingredient and production-related costs. As a result, these competing producers may be able to offer their products to

customers at a lower price point. This could cause us to lower our prices, resulting in lower profitability or, in the alternative, cause

us to lose market share if we fail to lower prices. Furthermore, private label competitors are generally able to sell their products at

lower prices because private label products typically have lower marketing costs than their branded counterparts. If our products fail

to compete successfully with other branded or private label offerings, demand for our products and our sales volumes could be negatively

impacted.

Additionally, due to high levels of competition, certain

of our key retailers may demand price concessions on our products or may become more resistant to price increases for our products. Increased

price competition and resistance to price increases have had, and may continue to have, a negative effect on our results of operations.

We may not be able to successfully implement our business strategy

for our brands on a timely basis or at all.

We believe that our future success depends, in part,

on our ability to implement our strategy of leveraging our existing brands with our new products to maintain our market position in our

product categories; drive increased sales; acquire or establish new brands; and create strategic alliances including potential joint ventures.

Our ability to implement this strategy depends, among other things, on our ability to:

· compete successfully in the product categories in which we choose to operate;

· increase our brand recognition and loyalty;

· negotiate acquisitions and joint ventures on terms acceptable to us; and

If we fail to execute these and other important elements

of our business strategy, our business and results of operations could be adversely affected.

One key element of our business strategy is to introduce

timely, new, cost-effective, and appealing products and to innovate successfully within our existing product categories. However, consumer

tastes and preferences change rapidly, and evolve over time. Factors that may affect consumer tastes and preferences include:

Our future investments may not produce the results

we expect when we expect them for a variety of reasons including those described herein. Our future product development and innovation

will be reliant on our ability to identify and develop potential new growth opportunities. This process is inherently risky and will result

in investments of substantial time and resources for which we may not achieve any return or value. Successful product development and

innovation is also affected by our ability to launch new or improved products successfully and on a timely and cost-effective basis.

We may have to pay cash, incur debt, or issue equity,

equity-linked, or debt securities to fund our business strategy, or may be unable to fund that strategy. Any of these events could adversely

affect our financial results and our business. We could experience similar effects if we invest resources in a strategy that ultimately

proves unsuccessful. If, due to a failure of our strategy or any other reason, consumer demand for our products declines, our sales volumes,

results of operations, and our business could be negatively affected, and we may not be able to create or sustain growth or successfully

implement our business strategy.

Interruption of our supply chain could affect

our ability to manufacture or distribute products, could adversely affect our business and sales, and/or could increase our operating

costs and capital expenditures.

We have several supply agreements with suppliers and

co-packers that require them to provide us with certain ingredients, packaging, other inputs, and finished goods. For certain items, we

rely on a single supplier or co-packer as our sole source for the item. Our suppliers and co-packers are subject to risk, including labor

disputes, union organizing activities, financial liquidity, inclement weather, natural disasters, supply constraints, and general economic

and political conditions that could limit their ability to timely provide us with acceptable product. Although other sources are available

for these items, if our current sources are unable to fulfill our needs for any reason, we may not be able to timely engage a replacement

source that can timely provide us with acceptable products or on terms favorable to us or at all, which could disrupt our ability to manufacture

and distribute products. Such disruptions could have a material adverse effect on our business, consolidated financial condition or results

of operations.

Disruption of our manufacturing or distribution

chains or information technology systems, including disruption due to cybersecurity threats, could adversely affect our business.

The success of our business depends, in part, on maintaining

a strong manufacturing platform and we rely primarily on internal production resources to fulfill our manufacturing needs. Our ongoing

initiatives to expand our manufacturing platform and our productive capacity could fail to achieve such objectives and, in any case, could

increase our operating costs beyond our expectations and could require significant additional capital expenditures. If we cannot maintain

sufficient production, warehousing, and distribution capacity, either internally or through third party agreements, we may be unable to

meet customer demand and/or our manufacturing, distribution, and warehousing costs may increase, which could negatively affect our business.

Furthermore, damage or disruption to our manufacturing

or distribution capabilities due to weather, natural disaster, fire, environmental incident, terrorism, cybersecurity threats and other

security breaches, pandemic, strikes, the financial or operational instability of key distributors, warehousing, and transportation providers,

or other reasons could impair our ability to manufacture or distribute our products.

We rely on a limited number of production and distribution

facilities. A disruption in operations at any of these facilities or any other disruption in our supply chain relating to common carriers,

supply of raw materials and finished goods, or otherwise, whether as a result of casualty, natural disaster, power loss, telecommunications

failure, cybersecurity threat, terrorism, labor shortages, contractual disputes or other causes, could significantly impair our ability

to operate our business and adversely affect our relationship with our customers. Furthermore, our insurance coverage may not be adequate

to cover all related costs.

Our information technology systems are also critical

to the operation of our business and essential to our ability to successfully perform day-to-day operations. These systems include, without

limitation, networks, applications, and outsourced services in connection with the operation of our business. A failure of our information

technology systems to perform as we anticipate could disrupt our business and result in transaction errors, processing inefficiencies,

and sales losses, causing our business to suffer. In addition, our information technology systems may be vulnerable to damage or interruption

from circumstances beyond our control, including fire, natural disasters, systems failures, and cybersecurity threats. Cybersecurity threats

in particular are persistent, evolve quickly and include, without limitation, computer viruses, unauthorized attempts to access information,

denial of service attacks, and other electronic security breaches. Like our customers, suppliers, subcontractors and other third parties

with whom we do business generally, we expect that we will continue to be the subject of cybersecurity threats. In some cases, we must

rely on the safeguards put in place by the third parties with whom we do business to protect against security threats. We believe we have

implemented appropriate measures and controls and have invested in sufficient resources to appropriately identify and monitor these threats

and mitigate potential risks, including risks involving our customers and suppliers. However, there can be no assurance that any such

actions will be sufficient to prevent cybersecurity breaches, disruptions to mission critical systems, the unauthorized release of sensitive

information or corruption of data, or harm to facilities or personnel.

These threats and other events could disrupt our operations,

or the operations of our customers, suppliers, subcontractors and other third parties; could require significant management attention

and resources; could result in the loss of business, regulatory actions and potential liability; and could negatively impact our reputation

among our customers and the public. Any of these outcomes could have a negative impact on our financial condition, results of operations,

or liquidity.

Our debt and financial obligations could adversely

affect our financial condition, our ability to obtain future financing, and our ability to operate our business.

Although the Company does not have any indebtedness

outstanding as of December 31, 2024, the Company may incur indebtedness in the future. Outstanding debt obligations could adversely affect

our financial condition and limit our ability to successfully implement our business strategy. Furthermore, from time to time, we may

need additional financing to support our business and pursue our business strategy, including strategic acquisitions. Our ability to obtain

additional financing, if and when required, will depend on our operating performance, the condition of the capital markets, and other

factors. We cannot assure that additional financing will be available to us on favorable terms when required, or at all. If we raise additional

funds through the issuance of equity, equity-linked, or debt securities, those securities may have rights, preferences, or privileges

senior to those of our common stock, and, in the case of equity and equity-linked securities, our existing stockholders may experience

dilution. Although the Company believes that the Stockholders’ Agreement, dated as of October 1, 1999 (and as amended on December

24, 1999 and as extended in certain respects in eight extensions executed by certain of the parties to the Stockholders’ Agreement,

the last of which was dated as of December 31, 2009 (the “Stockholders’ Agreement”)), by and among Danone North America

Public Benefit Corporation or an affiliate thereof (collectively, “Danone”), Lifeway and certain Lifeway shareholders, is

invalid, the Stockholders’ Agreement purports to limit the Company’s ability to issue shares of Company common stock or convertible

securities outside of specified, limited situations without providing Danone a right of first refusal, in the case of issuances of Company

common stock, or first obtaining Danone’s prior consent, in the case of issuances of securities convertible into Company common

stock in excess of a specified amount. If the Stockholders’ Agreement is valid or if third parties are unwilling to participate

in transactions due to the uncertainty relating to the validity of the Stockholders’ Agreement, the Company may not be able to raise

additional funds through the issuance of equity or equity-linked securities.

As of December 31, 2024, we had $0 outstanding under

the Revolving Credit Facility and note payable. Our loan agreements contain certain restrictions and requirements that among other things:

· impose on us financial and operational restrictions.

Our ability to meet our debt service obligations will

depend on our future performance, which will be affected by the other risk factors described in this Annual Report on Form 10-K. If we

do not generate enough cash flow to pay our debt service obligations, we may be required to refinance all or part of our existing debt,

sell our assets, borrow more money or raise equity. There is no guarantee that we will be able to take any of these actions on a timely

basis, on terms satisfactory to us, or at all.

Our Revolving Credit Facility bears interest at variable

rates. If market interest rates increase, it will increase our debt service requirements, which could adversely affect our cash flow.

Our loan agreements also contain provisions that restrict our ability to:

· borrow money or guarantee debt;

· create liens;

· make specified types of investments and acquisitions;

· pay dividends on or redeem or repurchase stock;

· enter into new lines of business;

· enter into transactions with affiliates; and

· sell assets or merge with other companies.

These restrictions on the operation of our business

could harm our ability to execute on our business strategy by, among other things, limiting our ability to take advantage of financing,

merger and acquisition opportunities, and other corporate opportunities. Various risks, uncertainties, and events beyond our control could

affect our ability to comply with these covenants. Unless cured or waived, a default would permit lenders to accelerate the maturity of

the debt under the credit agreement and to foreclose upon the collateral securing the debt.

Loss of our key management or other personnel,

or an inability to attract such management and other personnel, could negatively impact our business.

We depend on the skills, working relationships,

and continued services of key personnel, including our experienced senior management team. We also depend on our ability to attract and

retain qualified personnel to operate and expand our business. If we lose one or more members of our senior management team whose responsibilities

cannot otherwise be distributed among our other officers, or if we fail to attract talented new employees, our business and results of

operations could be negatively affected.

Employee strikes and other labor-related

disruptions may adversely affect our operations.

We have a union contract governing the terms and

conditions of employment for a significant portion of our manufacturing workforce in Illinois. Although we believe union relations since

the union’s certification as the exclusive bargaining representative of this portion of our workforce have been amicable, there

is no assurance that this will continue in the future or that we will not be subject to future union organizing activity. There are potential

adverse effects of labor disputes with our own employees or by others who provide warehousing, transportation, and distribution, both

domestic and foreign, of our raw materials or other products. Strikes or work stoppages or other business interruptions could occur if

we are unable to renew collective bargaining agreements on satisfactory terms or enter into new agreements on satisfactory terms, which

could impair manufacturing and distribution of our products or result in a loss of sales, which could adversely impact our business, financial

condition, or results of operations. The terms and conditions of existing, renegotiated, or new collective bargaining agreements could

also increase our costs or otherwise affect our ability to fully implement future operational changes to enhance our efficiency or to

adapt to changing business needs or strategy.

Our intellectual property rights are valuable, and any inability

to protect them could reduce the value of our products and brands.

We consider our intellectual property rights,

particularly our trademarks, but also our copyrights, registered domain names, and proprietary trade secrets, technology, know-how, processes

and other proprietary rights to be a significant and valuable aspect of our business. We attempt to protect our intellectual property

rights by relying on a combination of trademark, copyright, trade dress, trade secret, and other intellectual property laws, and domain

name dispute resolution systems; as well as licensing agreements, third-party confidentiality, nondisclosure, and assignment agreements;

and by policing third-party misuses of our intellectual property. Our failure to obtain or maintain adequate protection of our intellectual

property rights, or any change in law or other changes that serve to lessen or remove the current legal protections of our intellectual

property, may diminish our competitiveness and could materially harm our business.

We also face the risk of claims that we have infringed

third parties’ intellectual property rights. Any claims of intellectual property infringement, even those without merit, could be

expensive and time consuming to defend, cause us to cease making, licensing, or using products that incorporate the challenged intellectual

property, require us to redesign or rebrand our products or packaging, divert management’s attention and resources, or require us

to enter into royalty or licensing agreements to obtain the right to use a third party’s intellectual property. Any royalty or licensing

agreements, if required, may not be available to us on acceptable terms or at all. Additionally, a successful claim of infringement against

us could result in our being required to pay significant damages, enter into costly license or royalty agreements, or stop the sale of

certain products, any of which could have a negative effect on our results of operations.

A substantial portion of our common stock

is held by members of the Smolyansky family and Danone, and they have the ability to control the outcome of matters submitted for stockholder

approval.

Our four largest shareholders, Julie Smolyansky

(the Company’s chief executive officer and the daughter of our founder), Edward Smolyansky (our former chief operations officer

and son of our founder), Ludmila Smolyansky (a former member of our Board and the widow of our founder) and Danone, beneficially owned

approximately 18%, 21%, 8% and 23% of the Company’s outstanding common stock, respectively, as of December 31, 2024. Certain of

these shareholders, together, could significantly influence any matter requiring approval by our stockholders, including the election

or removal of all of our directors, amendments to our articles of incorporation and the approval or rejection of any merger, change of

control, or other significant corporate transaction. It is unlikely that any person interested in acquiring Lifeway will be able to do

so without obtaining the consent of some combination of Julie Smolyansky, Edward Smolyansky, Ludmila Smolyansky and Danone. The interests

of the Smolyansky family members and Danone could differ from those of other stockholders in ways that could be adverse to the interests

of other stockholders. By exercising their influence, such stockholders could cause Lifeway to take actions that are at odds with the

investment goals of institutional, short-term, non-voting, or other non-controlling investors, or that have a negative effect on our stock

price. Additionally, concentration of ownership could also harm the market price of our common stock if investors perceive disadvantages

in owning stock in a company of which a substantial portion of common stock is beneficially owned by a small number of stockholders.

Our business could be adversely affected

as a result of proposals to acquire the Company or other actions taken by stockholders related to a possible acquisition of the Company.

In September 2024, Danone publicly made an unsolicited

proposal to acquire all of the shares of Company common stock that it did not already own for $25.00 per share of Company common stock,

subject to due diligence, among other things. Then in November 2024, Danone revised its proposal to $27.00 per share of Company common

stock. Our Board carefully considered the initial proposal and the revised proposal in consultation with the Company’s independent

financial and legal advisors, and ultimately determined that both proposals substantially undervalued the Company and were not in the

best interests of the Company or its stockholders or other stakeholders. These proposals, similar proposals that we may receive in the

future and any other actions by stockholders or others relating to a potential change of control transaction involving the Company could

interfere with our ability to execute our strategic plans, make it more difficult to attract and retain qualified executives and employees,

cause management distraction, require us to utilize more resources than anticipated towards review of strategic alternatives and result

in the loss of potential business opportunities, any of which could have a material negative impact on the Company. In addition, our business

and operations may be harmed to the extent that our customers or suppliers or others believe that we cannot effectively compete in the

marketplace without completing a transaction, or if there is customer, supplier or employee uncertainty surrounding the future direction

of our product offerings and our strategy. There can be no assurance that any such transaction will be completed now or in the future.

We have had to, and may continue to be required

to, incur fees and other expenses related to Danone’s proposals, including for third-party advisors. Further, Danone’s proposals,

similar future proposals that we may receive in the future or any actual or perceived actions by our stockholders or others relating to

a potential transaction involving the Company may cause significant fluctuations in our stock price based upon temporary or speculative

market perceptions or other factors that do not necessarily reflect the Company’s underlying fundamentals and prospects.

The actions of certain of our stockholders

could cause us to incur significant expense, disrupt our business, result in a proxy contest or litigation and adversely impact our stock

price.

We value constructive input from investors and

regularly engage in dialogue with our stockholders regarding strategy and performance. Our Board and management team are committed to

acting in the best interests of all of our stockholders.

Two of the Company’s largest stockholders,

Edward Smolyansky and Ludmila Smolyansky, filed a Schedule 13D/A with the U.S. Securities and Exchange Commission (the “SEC”)

on August 14, 2024 announcing their intention, among other things, to nominate seven director candidates for election to our Board and

replace seven of the eight members of our Board. Edward and Ludmila Smolyansky subsequently filed a preliminary consent solicitation statement

with the SEC in furtherance of this objective, and they have made public statements critical of our Board, management and strategy, repeatedly

called for the sale of the Company and publicly supported a sale of the Company for $25 per share. A contested election with respect to

the Company’s directors could require us to incur substantial legal, public relations and other advisory fees and proxy solicitation

expenses. Further, we may choose to initiate, or may become subject to, litigation as a result of proposals by Edward and Ludmila Smolyansky

or other stockholders or proxy contests or matters relating thereto, which would serve as a further distraction to our Board and management

and could require us to incur significant additional costs.

We may be subject to continued or similar activism

in the future, which could cause us to incur significant expense, hinder execution of our business strategy and adversely impact the market

price of Company common stock. Stockholder actions, including potential proxy contests, require significant time and attention by management

and our Board, potentially interfering with our ability to execute our strategic plan. Such stockholder action could give rise to perceived

uncertainties as to our future, adversely affect our relationships with our employees, customers or suppliers and make it more difficult

to attract and retain qualified personnel and business partners. These perceived uncertainties may also be exploited by our competitors

or other stockholders, which could result in lost business opportunities and make it more difficult to execute on our long-term strategic

plan. If customers choose to delay, defer or reduce transactions with us or do business with our competitors instead of us, then our business,

financial condition and operating results would be adversely affected. We may be required to incur significant legal fees and other expenses

related to stockholder actions, and the attention of our management may be diverted by such actions. Any of these impacts could materially

and adversely affect our business, operating results and financial condition, and the market price of Company common stock could be subject

to significant fluctuation or otherwise be adversely affected. If individuals are elected or appointed to our Board with a specific agenda,

the ability of our Board to function effectively could be adversely affected, which could in turn adversely affect our ability to effectively

and timely implement our strategic plan and create additional value for our stockholders, and adversely affect our business, operating

results and financial condition.

Litigation regarding the Stockholders’

Agreement may be protracted and costly.

As previously disclosed by the Company, the Company

believes that the Stockholders’ Agreement is void ab initio and unenforceable. Danone has filed suit in the Circuit Court

of Cook County, Law Division, in part, to enforce the Stockholders’ Agreement. The litigation regarding the Stockholders’

Agreement may be protracted and expensive, and under certain circumstances, the Company may be required to reimburse Danone for its legal

fees incurred in connection with such litigation. Further, the uncertainty relating to the status of the Stockholders’ Agreement

may cause third parties to refuse to engage in activities that are purportedly prohibited by the Stockholders’ Agreement.

Our shareholder rights plan includes terms

and conditions that could discourage a takeover or other transaction that stockholders may consider favorable.

On November 4, 2024, in response to Danone’s

original proposal and Danone’s substantial ownership position in the Company, our Board approved and adopted the Shareholder Rights

Agreement with Computershare Trust Company, N.A., as rights agent (the “Rights Agreement”), and declared a dividend of one

preferred share purchase right (each, a “Right”) for each outstanding share of Company common stock to stockholders of record

at the close of business on November 18, 2024. Each Right entitles its holder, subject to the terms of the Rights Agreement, to purchase

from the Company one one-thousandth of a share of Series A Junior Participating Preferred Stock, no par value, of the Company at an exercise

price of $130.00 per Right, subject to adjustment. Rights will generally become exercisable only if any person or entity (or any persons

or entities acting as a group) acquires 20% or more of the outstanding shares of Company common stock (or, to the extent any person, entity

or group beneficially owned 20% or more of the outstanding shares of Company common stock as of immediately prior to the first public

announcement of the adoption of the Rights Agreement, such person, entity or group acquires any additional shares). If Rights become exercisable,

all holders of Rights (other than the person, entity or group triggering the Rights Agreement, whose Rights will become void and will

not be exercisable) will have the right to purchase from the Company for $130.00, subject to certain potential adjustments, shares of

Company common stock having a market value of twice that amount. The Rights Agreement expires on November 4, 2025, unless earlier terminated

or the Rights are redeemed or exchanged by the Board. Additional information regarding the Rights Agreement is contained in the Company’s

Current Report on Form 8-K filed with the SEC on November 5, 2024.

The Rights Agreement will cause substantial dilution

to any person, entity or group that acquires beneficial ownership of 20% or more of the outstanding shares of Company common stock (or,

to the extent any person, entity or group beneficially owned 20% or more of the outstanding shares of Company common stock as of immediately

prior to the first public announcement of the adoption of the Rights Agreement, such person, entity or group acquires any additional shares).

As a result, the overall effect of the Rights Agreement and the issuance of the Rights may be to discourage any person, entity or group

from gaining a control or control-like position in the Company or engaging in other tactics, potentially disadvantaging the interests

of the Company’s stockholders, without negotiating with the Board and without paying an appropriate control premium to all stockholders.

The Rights Agreement has similar provisions to those of other plans adopted by publicly-held companies in comparable circumstances. It

is intended to protect stockholders’ interests, including by providing the Board sufficient time to make informed judgments and

take actions that are in the best interests of all of the Company’s stockholders and other stakeholders. Nevertheless, the Rights

Agreement may be considered to have certain anti-takeover effects, including potentially discouraging a third party from attempting to

obtain a substantial position in the Company common stock or seeking to obtain control of the Company and discouraging a takeover attempt

that stockholders may consider favorable or that could result in a premium over the market price of Company common stock. Even in the

absence of a takeover attempt, the Rights Agreement may adversely affect the prevailing market price of Company common stock if it is

viewed as discouraging takeover attempts in the future.

Adverse economic conditions in the United

States or any of the other countries in which we conduct significant business in the future could negatively affect our business, financial

condition and results of operations.

Many of our products may be considered discretionary

items for consumers. Consumer spending on discretionary products is influenced by general economic conditions and the availability of

discretionary income. Adverse economic conditions in the United States, our primary market, or any of the other jurisdictions in which

we conduct significant business in the future, such as the current inflationary economic environment, rising interest rates, financial

distress caused by recent or potential bank failures and the associated banking crisis, an economic recession, depression or downturn,

a tightening of the credit markets, high energy prices or higher unemployment levels, may lead to decreased consumer spending, reduced

credit availability and a decline in consumer confidence and demand, each of which poses a risk to our business. For example, US and global

markets have in the past experienced volatility and disruption due to interest rate and inflation increases, as well as the continued

escalation of geopolitical tensions, including those as a result of the conflicts between Russia and Ukraine and in the Middle East. Although

our business has not yet been materially negatively impacted by such inflationary pressures, we cannot be certain that neither we nor

our consumers will be materially impacted by continued pressures.

The change in administration following the 2024

United States presidential election could further impact trade and tariff policies, and could also result in substantial changes to fiscal,

tax, or regulatory policies that may impact our business. These additional tariffs, as well as a government’s adoption of “buy

national” policies or retaliation by another government against such tariffs or policies have introduced significant uncertainty

into the market and may affect the prices of and demand for our products, as well as the cost to acquire machinery and equipment from

international sources, which could have a material and adverse effect on our business, financial condition and results of operations.

Other significant events may impact economic conditions

and affect discretionary spending, including events such as catastrophic environmental disasters or global pandemics. As global economic

conditions continue to be volatile and economic uncertainty remains, trends in consumer discretionary spending also remain unpredictable

and subject to reductions due to credit constraints and uncertainties about the future. A decrease in consumer spending or in retailer

and consumer confidence and demand for our products could have a significant negative impact on our net sales and profitability, including

our operating margins and return on invested capital. These economic conditions could cause some of our retail customers or suppliers

to experience cash flow or credit problems and impair their financial condition, which could disrupt our business and adversely affect

product orders, payment patterns and default rates and increase our bad debt expense.

RISKS RELATED TO OUR INDUSTRY

The consolidation of our customers or the

loss of any of our largest customers could negatively impact our sales and results of operations.

Customers, such as supermarkets and food distributors,

continue to consolidate. This consolidation has produced larger, more sophisticated organizations with increased negotiating and buying

power that are able to resist price increases or demand increased promotional programs, as well as operate with lower inventories, decrease

the number of brands that they carry and increase their emphasis on private label products, all of which could negatively impact our business.

The consolidation of retail customers also increases the risk that a significant adverse impact on their business could have a corresponding

material adverse impact on our business.

Two of our customers together accounted for 25%

of our net sales in the fiscal year ended December 31, 2024. Where we enter into written agreements with our customers, they are generally

terminable after short notice periods by the customer. In addition, our customers sometimes award contracts based on competitive bidding,

which could result in lower profits for contracts we win and the loss of business for contracts we lose. The loss of any large customer,

the reduction of purchasing levels, or the cancellation of any business from a large customer for an extended period of time could negatively

affect our sales and results of operations.

We rely on sales made by or through our independent

distributors to customers. Distributors purchase directly for their own account for resale. The loss of, or business disruption at, one

or more of these distributors may harm our business. If we are required to obtain additional or alternative distribution agreements or

arrangements in the future, we cannot be certain that we will be able to do so on satisfactory terms or in a timely manner. Our inability

to enter into satisfactory distribution agreements may inhibit our ability to implement our business plan or to establish markets necessary

to expand the distribution of our products successfully.

We are subject to the risk of product contamination

and product liability claims, which could harm our reputation, force us to recall products and incur substantial costs.

The sale of food products for human consumption involves

the risk of injury to consumers. Such injuries may result from tampering by unauthorized third parties, inadvertent mislabeling, product

contamination or spoilage, including the presence of foreign objects, substances, chemicals, other agents, or residues introduced during

the storage, processing, handling or transportation phases. We also may be subject to liability if our products or production processes

violate applicable laws or regulations, including environmental, health, and safety requirements, or in the event our products cause injury,

illness, or death.

Under certain circumstances, we may be required to

recall or withdraw products, suspend production of our products, or cease operations, which may lead to a material adverse effect on our

business. In addition, customers may cancel orders for such products as a result of such events. Even if a situation does not necessitate

a recall or market withdrawal, and even if we and each of our co-packers and suppliers comply in all material respects with all applicable

laws and regulations, we may become subject to claims or lawsuits relating to such matters. Even if a product liability claim is unsuccessful

or is not fully pursued, the negative publicity surrounding any assertion that our products caused illness or physical harm, including

the risk of reputational harm being magnified and/or distorted through the rapid dissemination of information over the Internet, including

through news articles, blogs, chat rooms, and social media, could adversely affect our reputation with existing and potential customers

and consumers and our corporate and brand image. Moreover, claims or liabilities of this type might not be covered by our insurance or

by any rights of indemnity or contribution that we may have against others. We maintain product liability and product recall insurance

in amounts that we believe to be adequate. However, we cannot be sure that we will not incur claims or liabilities for which we are not

insured or that exceed the amount of our insurance coverage. A product liability judgment against us or a product recall could have a

material adverse effect on our business, consolidated financial condition, results of operations or liquidity.

We rely on independent certification for several of our products

and facilities.

We rely on independent certification, such as certifications

of our products as “organic,” or “gluten-free,” to differentiate our products from others. The loss of any independent

certifications could adversely affect our market position as a probiotic-based product and natural, “better for you” foods

company, which could harm our business. We rely on independent SQF certification at some of our facilities, a certification that some

of our customers require us to maintain.

We must comply with the requirements of independent

organizations or certification authorities in order to label our products as certified. For example, we can lose our “organic”

certification if a manufacturing plant becomes contaminated with non-organic materials, or if it is not properly cleaned after a production

run. In addition, all organic raw materials must be certified organic or organic compliant. Our products could lose their organic certifications

if our raw material suppliers lose their organic certifications. Similarly, we could lose our SQF certification if we do not meet the

requirements of the SQF Code. The loss of these certifications could cause us to lose customers that require Lifeway products and/or facilities

to carry some or all of them, which could negatively affect our sales and results of operations.

Increases in the cost of milk could reduce our

gross margin and profit.

Conventional and organic milk, our primary raw material,

is an agricultural commodity that is subject to price fluctuations. Conventional milk prices were higher in fiscal 2024 than the prior

year, and there can be no assurance that such prices will remain at these levels in the future. The supply and price of milk may be impacted

by, among other things, weather, natural disasters, real or perceived supply shortages, lower dairy and crop yields, general increases

in farm inputs and costs of production, political and economic conditions, labor actions, government actions, and trade barriers. Increases

in the market price for milk or over-order premiums charged by producers may also impact our ability to enter into purchase commitments

at a fixed price. There can be no assurance that our purchasing practices will mitigate future price risk. As a result, increases in the

cost of milk could have an adverse impact on our profitability.

In addition, the dairy industry continues to experience

periodic imbalances between supply and demand for organic milk. Industry regulation and the costs of organic farming compared to costs

of conventional farming can impact the supply of organic milk in the market. Oversupply levels of organic milk can increase competitive

pressure on our products and pricing, while supply shortages can cause higher input costs and reduce our ability to deliver product to

our customers. Cost increases in raw materials and other inputs could cause our profits to decrease significantly compared to prior periods,

as we may be unable to increase our prices to offset the increased cost of these raw materials and other inputs. If we are unable to obtain

raw materials and other inputs for our products or offset any increased costs for such raw materials and inputs, our business could be

negatively affected.

Reduced availability of raw materials and other

inputs, as well as increased costs for them, could adversely affect us.

Our business depends heavily on raw materials

and other inputs in addition to conventional and organic raw milk, such as sweeteners, diesel fuel, packaging material, resin, and other

commodities. Our raw materials are generally sourced from third-party suppliers, and we are not assured of continued supply, pricing,

or exclusive access to raw materials from any of these suppliers. In 2024, costs to us increased modestly due to inflationary price increases.

However, for market conditions or competitive reasons, our customer pricing actions may lag input cost changes, or we may not be able

to pass along the full effect of increases in raw materials and other input costs as we incur them.

The organic ingredients we use in some of our

products are less plentiful and available from a fewer number of suppliers than their conventional counterparts. Competition with other

manufacturers in the procurement of organic product ingredients may increase in the future if consumer demand for organic products exceeds

the supply.

Our business is subject to various food, environmental,

and health and safety laws and regulations, which may increase our compliance costs, subject us to liabilities, or otherwise adversely

affect our business.

Our business operations are subject to numerous requirements

in the United States relating to food safety, production, and marketing, as well as the protection of the environment, and health and

safety matters. The food production and marketing industry is subject to a variety of federal, state, local, and foreign laws and regulations,

including food safety requirements related to the ingredients, manufacture, processing, storage, marketing, advertising, labeling, and

distribution of our products, as well as those related to worker health and workplace safety. Our activities, both in and outside of the

United States, are subject to extensive regulation. We are regulated by, among other federal and state authorities, the FDA, USDA, the

U.S. Federal Trade Commission (“FTC”), and the U.S. Departments of Commerce, and Labor, as well as by similar authorities

in the foreign countries in which we do business. Environmental laws including the Clean Air Act, the Clean Water Act, the Comprehensive

Environmental Response, Compensation and Liability Act of 1980, as amended, and the National Organic Standards of the U.S. Department

of Agriculture, as well as similar state and local statutes and regulations in the United States and in each of the foreign countries

in which we do business apply to our business operations as well. These laws and regulations govern, among other things, air emissions

and the discharge of wastewater and other pollutants, the use of refrigerants, the handling and disposal of hazardous materials, and the

cleanup of contamination in the environment. In addition, the marketing and advertising of our products could make us the target of claims

relating to alleged false or deceptive advertising under federal, state, and foreign laws and regulations, and we may be subject to initiatives

that limit or prohibit the marketing and advertising of our products to children.

We are also subject to federal laws and regulations

relating to our organic products and production. For example, as required by the National Organic Program (“NOP”), we rely

on third parties to certify certain of our products and production locations as organic. Regulations and formal and informal positions

taken by the NOP pursuant to the Organic Foods Production Act of 1990, which created the NOP, are subject to continued review and scrutiny.

Changes in these laws or regulations or the introduction

of new laws or regulations could increase our compliance costs, increase other costs of doing business for us, our customers, or our suppliers,

or restrict our actions, which could adversely affect our results of operations. In some cases, new laws and regulations or other federal

and state regulatory initiatives could interrupt distribution of our products or force changes in our production processes and our products.

Governmental regulations also affect taxes and levies, healthcare costs, energy usage, immigration, and other labor issues, all of which

may have a direct or indirect effect on our business or those of our customers or suppliers. These costs could negatively affect our results

of operations and financial condition. Further, if we are found to be in violation of applicable laws and regulations in these areas,

we could be subject to civil remedies, including third-party claims for property damage or personal injury, fines, injunctions, recalls,

cleanup costs, and other civil sanctions, as well as potential criminal sanctions, any of which could have a material adverse effect on

our business.

ITEM 1B. UNRESOLVED

STAFF COMMENTS

None.

ITEM 1C. CYBERSECURITY

Risk Management and Strategy

Our cybersecurity program is designed to assess,

identify, and manage material risks from cybersecurity threats, and protect and preserve the confidentiality, integrity, and continued

availability of all information owned by, or in the care of, the Company.Cybersecurity risks are incorporated into the Company’s

broader risk management process to evaluate and address cybersecurity risks in alignment with our business objectives and operational

needs. As part of the cybersecurity program, we utilize a combination of internal technology, which we continue to analyze and update

as necessary, and a third-party managed security service provider and their platform to monitor, evaluate and respond to cyber activity.

We monitor and assess the information gathered by our security tools and services to identify gaps, exposures, or weaknesses in our overall

security approach, and make the necessary changes to address such findings.

Impact of Cybersecurity Risks and Threats

We are not aware of having experienced any risks

from cybersecurity threats or incidents through the date of this Report that have materially affected the Company, its business strategy,

results of operation or financial condition or are reasonably likely to have such an effect over the long term. This does not guarantee

that future incidents or threats will not have a material impact or that we are not currently the subject of an undetected incident or

threat that may have such an impact.

Additional information on cybersecurity risk we

face is discussed in Part I, Item A – Risk Factors, which should be read in conjunction with the foregoing information.

Governance

Board of Directors

Our Board of Directors oversees our risk management

process, and cybersecurity risks are monitored as a part of the broader program.Our Board has delegated the primary responsibility to

oversee risks from cybersecurity threats to the Audit and Corporate Governance Committee. The Chief Financial Officer presents updates

to the Audit and Corporate Governance Committee and the full Board of Directors, on, among other things, the Company’s cyber risks

and threats, the status of projects to strengthen the Company’s information security systems, and the emerging threat landscape.

Management

Our Chief Financial Officer is responsible for management

oversight of our information security program and controls, which includes cybersecurity risk management.Our Director of IT (“Director”)

is responsible for the development, operation, and maintenance of our information security program and controls.The Director has extensive

experience in the information technology field, and cybersecurity knowledge and skills gained through relevant experiences. The Director

and Chief Financial Officer regularly review potential risks and measures implemented by the Company to identify and mitigate cyber security

risks.

ITEM 2. PROPERTIES

We operate the following facilities:

Location Owned / Leased Principal Use

Morton Grove, Illinois Owned Production facility, principal executive offices

Niles, Illinois Owned Warehousing and distribution, administrative offices

Lifeway believes that its facilities are adequate

for its current needs and that suitable additional space will be available on commercially acceptable terms as required. We believe that

we have adequate insurance coverage for all our properties.

ITEM 3. LEGAL PROCEEDINGS

From time to time, we are engaged in litigation matters

arising in the ordinary course of business. While the results of litigation and claims cannot be predicted with certainty, Lifeway believes

that no such matter is reasonably likely to have a material adverse effect on our financial position or results of operations.

ITEM 4. MINE

SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5. MARKET FOR

REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

The Company’s common stock is listed on the

Nasdaq Global Market under the symbol “LWAY.” Trading commenced on March 29, 1988. As of March 7, 2025, there were approximately

53 shareholders of record of our common stock.

Dividend Policy

Lifeway does not routinely declare and pay dividends.

From time to time however our Board of Directors may declare and pay dividends depending on our operating cash flow, financial condition,

capital requirements and such other factors as the Board of Directors may deem relevant.

There were no dividends declared or paid in fiscal

2024 or 2023.

Purchases of Equity Securities by the Issuer

None.

ITEM 6. [RESERVED]

ITEM 7. MANAGEMENT’S

DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the financial

condition and results of operations as of and for the years ended December 31, 2024 and 2023 should be read in conjunction with the audited

consolidated financial statements and the notes to those statements that are included elsewhere in this Annual Report on Form 10-K. In

addition to historical information, the following discussion contains certain forward-looking statements within the “safe harbor”

provisions of the Private Securities Litigation Reform Act of 1995. These statements relate to our future plans, objectives, expectations

and intentions. These statements may be identified by the use of words such as “may,” “could,” “believe,”

“future,” “depend,” “expect,” “will,” “result,” “can,” “remain,”

“assurance,” “subject to,” “require,” “limit,” “impose,” “guarantee,”

“restrict,” “continue,” “become,” “predict,” “likely,” “opportunities,”

“effect,” “change,” and “estimate,” and similar terms or terminology, or the negative of such terms

or other comparable terminology. Although we believe the expectations expressed in these forward-looking statements are based on reasonable

assumptions within the bounds of our knowledge of our business, our actual results could differ materially from those discussed in these

statements. Factors that could contribute to such differences include, but are not limited to, those discussed in the “Risk Factors”

section in Part I, Item 1A. We undertake no obligation to update publicly any forward-looking statements for any reason even if new information

becomes available or other events occur in the future.

Recent Developments

Unsolicited Proposal

On November 5, 2024, we announced that our board

of directors (our “Board”) determined, after careful and thorough consideration in consultation with the Company’s independent

financial and legal advisors, that the unsolicited proposal made on September 23, 2024 by Danone North America PBC (“Danone”)

to acquire all of the shares of the Company that it did not already own for $25.00 per share, substantially undervalued the Company and

was not in the best interests of the Company or its stockholders or other stakeholders. In connection with that determination, we entered

into a Shareholder Rights Agreement with Computershare Trust Company, N.A., as rights agent (the “Rights Agreement”). Pursuant

to the Rights Agreement, our Board declared a dividend of one preferred share purchase right (each a “Right”) for each outstanding

share of Company common stock to stockholders of record as of the close of business on November 18, 2024. Each Right entitles its holder,

subject to the terms of the Rights Agreement, to purchase from the Company one one-thousandth of one share of Series A Junior Participating

Preferred Stock, no par value, of the Company at an exercise price of $130.00 per Right, subject to adjustment. Rights also attach to

any shares of Company common stock that become outstanding after November 18, 2024 and prior to the earlier of the Distribution Time (as

defined in the Rights Agreement) and the redemption or expiration of the Rights, and in certain other circumstances described in the Rights

Agreement.

On November 15, 2024, Danone revised its offer

to acquire all of the shares of the Company that it did not already own from $25.00 per share to $27.00 per share. On November 20, 2024,

we announced our Board’s determination that, after careful and thorough consideration in consultation with the Company’s independent

financial and legal advisors, the revised unsolicited proposal substantially undervalued the Company and was not in the best interests

of the Company or its stockholders or other stakeholders. On November 26, we announced additional information regarding the information

the Board used to come to this determination.

Debt Refinancing

On February 5, 2025,

the Company entered into the Fifth Modification to the Amended and Restated Loan and Security Agreement (the “Fifth Modification”)

with its current lender. The Fifth Modification, among other things, (i) increased the commitment for revolving loans under the Credit

Agreement from $5,000 to $25,000, with interest payable at either the lender Base Rate (the Prime Rate minus 1.00%) or the SOFR plus 1.75%,

(ii) extended the termination date of the Credit Agreement to February 5, 2028 and (iii) replaced the quarterly minimum working capital

financial covenant with a financial covenant to maintain a maximum cash flow leverage ratio of no greater than 2.00 to 1.00 for each fiscal

quarter commencing with the fiscal quarter ending March 31, 2025. The remaining material terms and conditions of the Credit Agreement

remain substantially unchanged. The Company had no outstanding borrowings at the time of entry into the Fifth Modification.

Products

In October 2024, we began to roll out our first

products with 100% lactose free labeling. Our products were already up to 99% lactose free, so we are pleased to further attract consumers

with our new Organic Whole Milk Flavor Fusion items that have this added benefit, along with decreased sugar content. In demand flavors

including Hot Honey, Matcha Latte, and Passionfruit Lychee are new additions to our portfolio. The entire lineup is loaded with high-quality

bioavailable nutrients, and plays to our strengths, as our organic products have been incredibly successful to date.

We expect health and wellness trends to continue to

be a tailwind for our entire premium product portfolio. We plan to continue to invest behind our key products to capture more and more

of this growing market,

Distribution Strategy

In September 2024, we announced our first expansion

of Kefir distribution in the South African market. In November 2024, we announced our expansion within Dubai and the UAE. The offering

of 32oz Lifeway Kefir, 8oz Lactose-Free Lifeway Kefir, ProBugs and farmer cheese, exported from the United States, is expected to begin

shipping in the first quarter of 2025 and will become available in supermarkets and hypermarkets in Dubai and across the Emirates. We

are taking a measured, and thoughtful approach to global expansion, as we seek markets that are primed for success and can be accessed

without a major initial investment.

Trends and Uncertainties

Current Macroeconomic Environment

We have not experienced significant supply chain disruptions

or labor supply shortages and have continued to satisfy customer and consumer demand for our products. Management continues to proactively

manage the supply and transportation of materials used to produce and package our products, staffing, and transportation of our products

to customers. This proactive planning has allowed the Company to meet increased demand.

Results of Operations

Comparison of Year Ended December 31, 2024 to Year

Ended December 31, 2023 (in thousands)

The following table presents certain information concerning

our financial results, including information presented as a percentage of consolidated net sales:

Year Ended December 31,

$ % $ %

Other income (expense):

Gain (loss) on sale of property and equipment (8 ) 0.0% 34 0.0%

Total other income (expense) 117 0.0% (346 ) (0.2% )

Net Sales

Net sales were $186,820 for the year ended December

31, 2024, an increase of $26,697 or 16.7% versus prior year. The net sales increase was primarily driven by higher volumes of our branded

drinkable kefir.

Gross Profit

Gross profit as a percentage of net sales decreased

to 26.0% during the year ended December 31, 2024 from 26.5% during the same period in 2023. The decrease versus the prior year was driven

by the unfavorable impact of milk pricing, and to a lesser extent the increase in other input costs, partially offset by favorable transportation

costs.

Selling Expenses

Selling expenses increased by $2,967 to $14,743

during the year ended December 31, 2024 from $11,776 during the same period in 2023. Selling expenses as a percentage of net sales increased

to 7.9% during the year ended December 31, 2024 from 7.4% during the same period in 2023. The increase is primarily a result of our continued

investments in marketing activities to drive brand awareness and sales volumes.

General and Administrative Expenses

General and administrative expenses increased

Source: SEC EDGAR (public domain) · 10-K for the period ended 2024-12-31, filed 2025-03-14 · accession 0001683168-25-001592

Filing HTML rendered to line-structured narrative text by the shipped reducer (datafeeds.edgar_fulltext.visible_text, keep_table_headers=True): scripts and inline-XBRL headers are dropped, and table content is reduced to its short label cells — numeric table data is not rendered and is therefore not counted. The same rendering is used for every year, so a year-over-year comparison is like for like.

The text is our rendering of the filing, not a facsimile: original pagination, typography and tables are not reproduced, and the numbers live in the financial statements (FA).

The outline locates item HEADINGS in this document. Only Items 1A and 7 have certified boundaries elsewhere in the terminal (the redline and the narrative-overlap number); every span here runs from one heading found to the next heading found.

How the outline was chosen. It is the longest chain of item headings that runs forward through both the document and the standard item order: 23 headings are on that chain and 17 further heading-shaped lines are not — the table-of-contents echo of every item, cross-references and exhibit-list mentions. Each entry's length is measured from its heading to the next heading on the chain.